- Funding
- €15M seed
ShanX Medtech is a Rotterdam-based diagnostics company that raised a €15 million seed in 2026 to advance its in-vitro platform for rapid antimicrobial susceptibility testing — identifying effective antibiotics far faster than conventional culture methods. Antimicrobial resistance is a declared EU public-health priority, and the funding supports clinical validation and market launch.